Jason Rifkin

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD.

Fox Rothschild LLP engages in the provision of legal services. Its practice areas include animal law, automotive, construction, business, corporate, drone law, employee benefits and compensation, entertainment and sports law, environmental, family law, fashion law, financial services industry, health law, insurance, international, immigration, media and defamation, nonprofit organizations, privacy and security, public companies, real estate, securities industry, taxation and wealth planning, technology, transportation and logistics, valuation law, and others. The company was founded by Edwin Fox and Jerome Rothschild in 1907 and is headquartered in Philadelphia, PA.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Equilibrium BV is a private company based in Voeren, Belgium that was founded in 2017. The Belgian company manufactures and sells breads & pastries and provides dining services.

Equilibrium BV is a private company based in Voeren, Belgium that was founded in 2017. The Belgian company manufactures and sells breads & pastries and provides dining services.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD.

PhageNova Bio, Inc. is a biotechnology company that is developing a modular, bacteriophage-based platform for targeted gene expression in cancer, vaccination, and molecular imaging. PhageNova Bio is based in Scarsdale, NY. The company's lead cancer construct is designed to selectively target tumor-associated blood vessels and tumor cells, resulting in the expression of TNF-?, an anti-tumor agent, specifically and exclusively in tumors. The company has extensively validated tumor targeting and selective gene expression capabilities, and therapeutic efficacy was observed in the absence of dose-limiting toxicity in multiple species and several tumor models. The company was founded by Renata Pasqualini, Wadih Arap, Steven K. Libutti, Juri G. Gelovani, and the CEO is Jason A. Rifkin.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

PhageNova Bio, Inc. is a biotechnology company that is developing a modular, bacteriophage-based platform for targeted gene expression in cancer, vaccination, and molecular imaging. PhageNova Bio is based in Scarsdale, NY. The company's lead cancer construct is designed to selectively target tumor-associated blood vessels and tumor cells, resulting in the expression of TNF-?, an anti-tumor agent, specifically and exclusively in tumors. The company has extensively validated tumor targeting and selective gene expression capabilities, and therapeutic efficacy was observed in the absence of dose-limiting toxicity in multiple species and several tumor models. The company was founded by Renata Pasqualini, Wadih Arap, Steven K. Libutti, Juri G. Gelovani, and the CEO is Jason A. Rifkin.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.